content

Gerresheimer AG on growth course

Gerresheimer AG further accelerated its revenue growth in the third quarter of 2021. โ€œThe third quarter once again shows the success of our growth...

Chiesi Research Centre: 10 years scientific innovation serving the community

The Chiesi Research Centre celebrates its 10th anniversary. The Groupโ€™s main research hub covers 20,000 square metres, a building which was inaugurated in October...

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Enesi Pharma has entered into an agreement with the US National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to...

Silence and Hansoh partner to develop siRNA-based treatments

Silence Therapeutics and Hansoh Pharmaceutical have entered a partnership to develop small-interfering ribonucleic acid (siRNAs) drugs for three undisclosed targets using the formerโ€™s mRNAi...

Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration

Antios Therapeutics, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment...

Moleculin obtains UK MHRA authorisation for Phase Ia trial of Covid-19 drug

Moleculin Biotech has obtained the UK Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation to initiate a Phase Ia clinical trial of its drug,...

Stevanato Group Wins Pharma Innovation Award For AI-ready Vision Robot Unit (VRU)

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has been recognized...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read